[{"status": "Ongoing", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077857"], "brand_name": ["ENOXAPARIN SODIUM"], "generic_name": ["ENOXAPARIN SODIUM"], "manufacturer_name": ["Cardinal Health 107, LLC", "Sandoz Inc"], "product_ndc": ["55154-3540", "55154-3541", "55154-3542", "55154-3543", "55154-3544", "0781-3238", "0781-3246", "0781-3256", "0781-3262", "0781-3268", "0781-3298", "0781-3299"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["ENOXAPARIN SODIUM"], "rxcui": ["854228", "854235", "854238", "854241", "854248", "854245", "854252"], "spl_id": ["69a14cc6-8c40-4be6-a5eb-cd4f9def8abe", "82c50153-58b8-4c35-8fc2-1d9b3d3ac7de"], "spl_set_id": ["5e7568a6-cf8a-4de2-86ba-b94c8ab4c806", "38f60bd8-b518-4098-a808-b8f5a3ae6a3a"], "package_ndc": ["55154-3540-5", "55154-3541-5", "55154-3542-5", "55154-3543-5", "55154-3544-5", "0781-3238-01", "0781-3238-63", "0781-3246-02", "0781-3246-64", "0781-3256-03", "0781-3256-66", "0781-3262-04", "0781-3262-68", "0781-3268-05", "0781-3268-69", "0781-3298-04", "0781-3298-68", "0781-3299-05", "0781-3299-69"], "original_packager_product_ndc": ["0781-3238", "0781-3246", "0781-3256", "0781-3262", "0781-3268"], "upc": ["0055154354059", "0055154354455", "0055154354257", "0055154354158"], "unii": ["8NZ41MIK1O"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "97380", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "KS", "recall_number": "D-0597-2025", "product_description": "Enoxaparin Sodium Injection, USP, 30 mg/0.3 mL, packaged in 0.3 mL prefilled syringes further packaged in bags of 5 prefilled syringes, Rx Only, Dist. by: Sandoz Inc., Princeton, NJ 08540, Outer package - NDC 55154-3543-5, Inner label - NDC 0781-3238-01", "product_quantity": "10 bags", "reason_for_recall": "Correct Labeled Product Mispack: Bags labeled for Enoxaparin Sodium Injection, 80 mg/0.8 mL, contained Enoxaparin Sodium Injection, 30 mg/0.3 mL", "recall_initiation_date": "20250805", "center_classification_date": "20250822", "report_date": "20250903", "code_info": "Outer package - NDC 55154-3543-5, Lot SAD08033AA   Inner label - NDC 0781-3238-01, Lot SAF13211A", "more_code_info": ""}, {"status": "Ongoing", "city": "Aurangabad, Maharashtra State", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA077568"], "brand_name": ["CIPROFLOXACIN"], "generic_name": ["CIPROFLOXACIN"], "manufacturer_name": ["Leading Pharma, LLC"], "product_ndc": ["69315-308"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CIPROFLOXACIN HYDROCHLORIDE"], "rxcui": ["309307"], "spl_id": ["8217ec14-6498-4c35-a5a9-511b451b9459"], "spl_set_id": ["545527e7-05c7-4dbf-ab32-b3fa463d55b0"], "package_ndc": ["69315-308-02", "69315-308-05", "69315-308-10"], "is_original_packager": [true], "upc": ["0369315308028", "0369315308059"], "unii": ["4BA73M5E37"]}, "product_type": "Drugs", "event_id": "96495", "recalling_firm": "FDC Limited", "address_1": "B-8 MIDC Industrial Area", "address_2": "Waluj District", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S", "recall_number": "D-0282-2025", "product_description": "Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India, NDC 69315-308-05", "product_quantity": "90960 bottles", "reason_for_recall": "Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle", "recall_initiation_date": "20250311", "center_classification_date": "20250317", "report_date": "20250326", "code_info": "Lot: 084A067, Exp 12/31/2025"}, {"country": "United States", "city": "Tampa", "address_1": "8500 Hidden River Pkwy", "reason_for_recall": "Lack of Assurance of Sterility: Failed preservative effectiveness testing.", "address_2": "", "product_quantity": "13,995 Bottles", "code_info": "Lot #221211, Expiry: 09/30/2015", "center_classification_date": "20150820", "distribution_pattern": "U.S. Nationwide and Puerto Rico", "state": "FL", "product_description": "Bromfenac Ophthalmic Solution, 0.09%, 1.7 mL Bottle, Rx Only.  Manufactured by Bausch & Lomb Incorporated Tampa, FL 33637.  NDC: 24208-439-01.", "report_date": "20150826", "classification": "Class II", "openfda": {}, "recalling_firm": "Bausch & Lomb, Inc.", "recall_number": "D-1349-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "71896", "termination_date": "20170407", "more_code_info": "", "recall_initiation_date": "20150817", "postal_code": "33637-1014", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M003"], "brand_name": ["HYDROGEN PEROXIDE"], "generic_name": ["HYDROGEN PEROXIDE"], "manufacturer_name": ["Vi-Jon, LLC"], "product_ndc": ["0869-0871"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["HYDROGEN PEROXIDE"], "rxcui": ["91349"], "spl_id": ["3deb136a-9aee-4364-e063-6294a90a626f"], "spl_set_id": ["e0a07631-6770-48b3-bf7b-19f3f3965cd9"], "package_ndc": ["0869-0871-72", "0869-0871-43", "0869-0871-45", "0869-0871-18", "0869-0871-99", "0869-0871-82"], "is_original_packager": [true], "unii": ["BBX060AN9V"]}, "product_type": "Drugs", "event_id": "96475", "recalling_firm": "Consumer Product Partners, LLC", "address_1": "1 Swan Dr", "address_2": "N/A", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "VA", "recall_number": "D-0302-2025", "product_description": "[CORRECT FRONT PANEL] Hydrogen Peroxide Topical Solution, USP, 32 FL OZ (1 QT) 946 mL per bottle, NDC 0869-0871-45; [INCORRECT BACK LABEL] Isopropyl alcohol 91%, Dist. by: Amazon.com Services, LLC, Seattle, WA 98109.", "product_quantity": "25,932 bottles", "reason_for_recall": "Labeling; Label Mixup; some bottles have an incorrect back label indicating 91% Isopropyl Alcohol", "recall_initiation_date": "20250307", "center_classification_date": "20250327", "report_date": "20250402", "code_info": "Lot 0643188, exp. date 10/22/2026"}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "2,938 cases", "code_info": "Product Code: 6308; Lots:  55134, EXP 08/28/2017, 56144, 56521, EXP 09/26/2017;  57495, EXP 11/13/2017; 58716, EXP 04/03/2018; 59486, EXP 06/15/2018; 59504, EXP 07/16/2018; 60426, EXP 08/02/2018; 61665,EXP 10/16/2018; 62033, 62058, EXP 11/12/2018.", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Q Care Continue Care for the non-ventilated patient. Contains, 1 Covered Yankauer, 3 Suction Toothbrush packages with Corinz Antiseptic Cleansing and Moisturizing Oral Rinse. Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6308 UPC 6 18029 83040 1", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0372-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-701-2015", "product_description": "Guanabenz Acetate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "2461 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Star", "state": "ID", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64619", "recalling_firm": "Palmer Natural Products", "address_1": "11665 W State St", "address_2": "N/A", "postal_code": "83669-5223", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Florida, Idaho, California and Hong Kong.  This product can be ordered on line.", "recall_number": "D-236-2013", "product_description": "Oxiracetam & Choline , Oxiracetam 460mg Choline 110mg capsules a) 30 count bottle, b) 60 count bottle, c) 90 count bottle, OTC, BoostYourGrade, LLC, Orlando, FL. 32826", "product_quantity": "472 - 30 count bottles; 203 - 60 count bottles; 458 - 90 count bottles", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: The products are unapproved drugs", "recall_initiation_date": "20130311", "center_classification_date": "20130401", "termination_date": "20130807", "report_date": "20130410", "code_info": "All lot codes"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA062831"], "brand_name": ["CEFAZOLIN"], "generic_name": ["CEFAZOLIN"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0781-3450", "0781-3451"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "PARENTERAL"], "substance_name": ["CEFAZOLIN SODIUM"], "rxcui": ["1665050", "1665052"], "spl_id": ["5fa78ed4-14be-485c-9e36-fd46a19d18fb"], "spl_set_id": ["18e7366a-1b3e-4010-8f4a-dd559d4f2146"], "package_ndc": ["0781-3450-70", "0781-3450-95", "0781-3451-70", "0781-3451-96"], "is_original_packager": [true], "unii": ["P380M0454Z"]}, "product_type": "Drugs", "event_id": "97140", "recalling_firm": "Sandoz Inc", "address_1": "100 College Rd W", "address_2": "", "postal_code": "08540-6604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0569-2025", "product_description": "Cefazolin for Injection, USP, 1 gram per vial, Sterile, For Intramuscular or Intravenous Use, Rx Only, Manufactured by Sandoz GmbH for Sandoz Inc. Princeton, NJ 08540, NDC: 0781 3451-70 (vial), NDC: 0781-3451-96 (carton).", "product_quantity": "208,300 vials", "reason_for_recall": "Labeling: Label Mix-Up; cartons of Cefazolin for Injection, USP 1 gram were found to contain vials labeled as penicillin G potassium for Injection, USP, 20 million Unit. The vials contained Cefozalin", "recall_initiation_date": "20250627", "center_classification_date": "20250806", "report_date": "20250709", "code_info": "Lot # PG4360, PG4362, Exp. 11/30/2027", "more_code_info": ""}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1745-2019", "product_description": "Abraxane 170 MG / 34 ML IVPB; Abraxane 200 MG / 40 ML IVPB; Abraxane 180 MG / 36 ML IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "New Delhi", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["THERACARE MAXIMUM STRENGTH PAIN RELIEF PATCH"], "generic_name": ["LIDOCAINE"], "manufacturer_name": ["Veridian Healthcare"], "product_ndc": ["71101-001"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["LIDOCAINE"], "rxcui": ["1737778"], "spl_id": ["28f04b12-7e69-bbd6-e063-6394a90a7792"], "spl_set_id": ["dfaf8a77-2276-4791-e053-2a95a90a3288"], "package_ndc": ["71101-001-06", "71101-001-24"], "is_original_packager": [true], "nui": ["N0000175682", "M0000897", "N0000175426", "N0000175976"], "pharm_class_epc": ["Amide Local Anesthetic [EPC]", "Antiarrhythmic [EPC]"], "pharm_class_cs": ["Amides [CS]"], "pharm_class_pe": ["Local Anesthesia [PE]"], "unii": ["98PI200987"], "upc": ["845717008785", "845717010566"]}, "product_type": "Drugs", "event_id": "95595", "recalling_firm": "Unexo Life Sciences Private Limited", "address_1": "B16, Sector 4, Bawana Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0065-2025", "product_description": "THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH, a) 1 patch (NDC 71101-001-24, UPC 8 45717 00878 5) and b) 6 patches (NDC 71101-001-06, UPC 8 45717 01056 6), Manufactured for: Veridian Healthcare, LLC, Gurnee, IL 60031", "product_quantity": "455,536 patches", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20241024", "center_classification_date": "20241122", "termination_date": "20250916", "report_date": "20241204", "code_info": "a) UPC 8 45717 00878 5 b) UPC 8 45717 01056 6", "more_code_info": ""}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0204-2018", "product_description": "Vitamin 9 A/B Lyophilized Vial, For IM Use, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "3612 vials", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lots: 06092017@2 BUD: 12/6/2017; 07212017@16 BUD: 1/17/2018; 07312017@26 BUD: 1/27/2018; 08182017@5 BUD: 2/14/2018; 09222017@2 BUD: 3/21/2018; 09292017@2 BUD: 3/28/2018; 10062017@2 BUD: 4/4/2018", "more_code_info": ""}, {"country": "United States", "city": "Ft Lauderdale", "address_1": "1458 NW 23rd Ave", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the products was found to contain sildenafil, an undeclared active pharmaceutical ingredient.", "address_2": "", "product_quantity": "", "code_info": "All lots", "center_classification_date": "20140320", "distribution_pattern": "Nationwide and France", "state": "FL", "product_description": "Silver Sword capsules, 180 mg, 16-count clamshell tin, UPC 1 234658 970128  12345   (labeling is in foreign language)", "report_date": "20140326", "classification": "Class I", "openfda": {}, "recalling_firm": "Fabscout Entertainment, Inc", "recall_number": "D-1170-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65892", "termination_date": "20191002", "more_code_info": "", "recall_initiation_date": "20130627", "postal_code": "33311-5147", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92898", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1115-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3% / Dextrose 10%, Total Volume = 250mL, IV Bag,  Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0404-1", "product_quantity": "40 bags", "reason_for_recall": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles", "recall_initiation_date": "20230817", "center_classification_date": "20230828", "termination_date": "20250327", "report_date": "20230906", "code_info": "Lot# 36-262157, Exp 8/21/2023      ;"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0704-2020", "product_description": "BUP 35MG/MORP 10MG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@18 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0584-2017", "product_description": "HCG in all strength including: 2,400, 9600,12,000 UNIT POWDER VIAL DROPS, HCG 11,000/B-12 UNITS SOLUTION, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0090-2015", "product_description": "Hydromorphone HCl (PF) 1 mg/mL injectable packaged in 30 mL or 60 mL syringes, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "20 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08182014@41, Exp 11/16/2014", "more_code_info": ""}, {"country": "United States", "city": "Eatontown", "address_1": "401 Industrial Way West", "reason_for_recall": "Labeling: Label Error on Declared Strength- bottles missing colored coded panel where strength of the product is displayed.", "address_2": "", "product_quantity": "32,006 bottles (AS1413A) and 32,198 bottles (AS1414A)", "code_info": "Lot #: AS1413A, AS1414A; Exp. 11/18", "center_classification_date": "20160919", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Amoxicillin For Oral Suspension, USP - Dye Free, 400 mg/5 mL, 100 mL (when reconstituted), Rx only,  Manufactured by: Hikma Pharmaceuticals, PO Box 182400, Amman 11118 - Jordan, Distributed by: West-Ward Pharmaceutical Corp. Eatontown, NJ 07724, NDC 00143-9887-01,", "report_date": "20160928", "classification": "Class III", "openfda": {}, "recalling_firm": "West-Ward Pharmaceuticals Corp.", "recall_number": "D-1515-2016", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "75083", "termination_date": "20170901", "more_code_info": "", "recall_initiation_date": "20160818", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "61918", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide Puerto Rico, U.S. Virgin Island, Libya, Saudi Arabia", "recall_number": "D-614-2013", "product_description": "5% Dextrose Injection USP, a) 250 mL (NDC 0409-7922-02), b) 500 mL (NDC 0409-7922-30), by Hospira, Inc., Lake Forest, IL 60045", "product_quantity": "267,288 units", "reason_for_recall": "Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.", "recall_initiation_date": "20120504", "center_classification_date": "20130621", "termination_date": "20150717", "report_date": "20130703", "code_info": "Lot #: a) 01-201-JT, Exp 7/12; b) Lot 91-054-JT, Exp 7/12", "more_code_info": ""}, {"country": "United States", "city": "Sugar Land", "address_1": "1075 W Park One Dr Ste 100", "reason_for_recall": "Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules", "address_2": "", "product_quantity": "", "code_info": "Lots: 10029291 Exp. 11/14/2019    10029292 Exp. 11/14/2019    10029977 Exp. 11/20/2019  10030041 Exp. 11/21/2019  10029977 Exp. 11/20/2019    10029978 Exp. 11/21/2019    10029979 Exp. 11/21/2019    10030041 Exp. 11/21/2019    10030043 Exp. 11/21/2019    10030396 Exp. 11/25/2019    10030960 Exp. 12/2/2019    10030961 Exp. 12/4/2019    10030962 Exp. 12/4/2019    10031010 Exp. 12/4/2019    10031011 Exp. 12/4/2019    10031012 Exp. 12/4/2019    10030960 Exp. 12/2/2019    10031086 Exp. 12/6/2019    10030960 Exp. 12/2/2019  10031263 Exp. 12/10/2019    10031262 Exp. 12/10/2019    10031413 Exp. 12/15/2019    10031463 Exp. 12/16/2019    10031696 Exp. 12/22/2019    10031947 Exp. 12/26/2019    10031948 Exp. 12/31/2019  10032414 Exp. 1/2/2020    10031978 Exp. 1/1/2020    10031948 Exp. 12/31/2019    10032412 Exp. 1/2/2020    10032413 Exp. 1/2/2020    10032687 Exp. 1/8/2020    10032723 Exp. 1/9/2020    10033037 Exp. 1/23/2020    10032929 Exp. 1/26/2020", "center_classification_date": "20191203", "distribution_pattern": "Nationwide.", "state": "TX", "product_description": "fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg/100 mL (2 mg/mL) in 0.9% Sodium Chloride , 100 mL bag, Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478  NDC 70092-1108-36", "report_date": "20191211", "classification": "Class II", "openfda": {}, "recalling_firm": "QuVa Pharma, Inc.", "recall_number": "D-0561-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84263", "termination_date": "20200605", "more_code_info": "", "recall_initiation_date": "20191112", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Greenville", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040253"], "brand_name": ["ETHOSUXIMIDE"], "generic_name": ["ETHOSUXIMIDE"], "manufacturer_name": ["PAI Holdings, LLC dba PAI Pharma"], "product_ndc": ["0121-0670"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ETHOSUXIMIDE"], "rxcui": ["251322"], "spl_id": ["14d8b71e-abd8-49d4-b4cc-82880e54db8c"], "spl_set_id": ["8a5cc930-0b36-48a8-9ad0-de633b208742"], "package_ndc": ["0121-0670-16"], "is_original_packager": [true], "upc": ["0301210670169"], "nui": ["N0000175753", "N0000008486"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["5SEH9X1D1D"]}, "product_type": "Drugs", "event_id": "88392", "recalling_firm": "PAI Holdings, LLC. dba Pharmaceutical Associates Inc", "address_1": "1700 Perimeter Rd", "address_2": "N/A", "postal_code": "29605-5252", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0723-2021", "product_description": "Ethosuximide Oral Solution USP 250 mg/5 mL, 16 fl oz (473 mL), Rx ONLY,  Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0670-16", "product_quantity": "75 cases (6 bottles/case)", "reason_for_recall": "Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.", "recall_initiation_date": "20210729", "center_classification_date": "20210812", "termination_date": "20221202", "report_date": "20210818", "code_info": "Lot: C9BC Exp. 31OCT2022"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076658"], "brand_name": ["FLUCONAZOLE"], "generic_name": ["FLUCONAZOLE"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-143", "55111-144", "55111-145", "55111-146"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FLUCONAZOLE"], "rxcui": ["197698", "197699", "197700", "197701"], "spl_id": ["69e67aa4-a859-7ab0-79df-d9bf8489998d"], "spl_set_id": ["d7fa1d79-4cd3-4a55-b74b-b31e82e616a3"], "package_ndc": ["55111-143-30", "55111-143-01", "55111-143-05", "55111-143-79", "55111-143-78", "55111-144-30", "55111-144-01", "55111-144-05", "55111-144-79", "55111-144-78", "55111-145-71", "55111-145-12", "55111-146-30", "55111-146-01", "55111-146-05", "55111-146-79", "55111-146-78"], "is_original_packager": [true], "upc": ["0355111145127"], "nui": ["N0000175487", "M0002083", "N0000182140", "N0000182141", "N0000185504"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_moa": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "unii": ["8VZV102JFY"]}, "product_type": "Drugs", "event_id": "76122", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0449-2017", "product_description": "Flucanozole Tablets, USP, 50 mg, a) 30 count (NDC 55111-143-30) and b) 100 count (NDC 55111-143-01) bottles, Rx Only, Mfd. by: Dr. Reddy's Laboratories, Bachupally 500 090 India", "product_quantity": "a) 2472 bottles, b) 780 bottles", "reason_for_recall": "Failed Dissolution Specifications; 18 month stability time point", "recall_initiation_date": "20161228", "center_classification_date": "20170130", "termination_date": "20171019", "report_date": "20170208", "code_info": "a)  30 count C500221, exp 12/2016, C502342, exp 03/2017  b)  100 count C500221, exp 12/2016, C502342, exp 03/2017", "more_code_info": ""}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "86 vials total (78/5mL vials and 8/50mL vials)", "code_info": "Lot # t11-21-2016@115, Exp 5/21/2017; t11-23-2016@109, Exp 5/27/2017; t12-13-2016@94, Exp 6/12/2017; t01-19-2017@85, Exp 7/22/2017; 02/01/2017@116, Exp 7/31/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "PROCAINE HCL SDV 1% INJ, Injection, 1%, Rx only, packaged in 5mL and 50 mL Glass/Single Dose vials, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0773-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Kearney", "state": "NE", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67260", "recalling_firm": "Slim Beauty USA", "address_1": "503 E 23rd St", "address_2": "N/A", "postal_code": "68847", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1220-2014", "product_description": "Dr. Ming's Chinese Capsule (Ginger 50 mg, Camellia Sinensis 50 mg, Malus Domestica 50 mg, Propetary Blend 300 mg Cynara Scolymus, Hoodia, Siruline, Chitosan, 60-count bottles, Distributed by Natural Products, Doral, FL 33178.", "product_quantity": "4 bottles", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: The product contains undeclared sibutramine and phenolphthalein. Sibutramine and phenolphthalein are not currently marketed in the United States, making this product an unapproved new drug.", "recall_initiation_date": "20131210", "center_classification_date": "20140407", "termination_date": "20170314", "report_date": "20140416", "code_info": "Lot #: 18 04 12, Exp 17 04 14"}, {"country": "United States", "city": "Rockford", "address_1": "1718 Northrock Ct", "reason_for_recall": "Failed Impurities/Degradation Specifications: out of specification result for Clonazepam Related Compound (RC) A (a known impurity) at 16 month timepoint.", "address_2": "", "product_quantity": "46,472 unit dose blister cards (10 cards of 10 tablets each)", "code_info": "Lot#: 3061784, Exp 11/16; 3067656, Exp 12/16; 3074902, Exp 08/17", "center_classification_date": "20161110", "distribution_pattern": "Nationwide", "state": "IL", "product_description": "Clonazepam Tablets, USP, 1.0 mg, packaged in a 100- count unit dose box of 10 x 10 blister cards, Rx only, Manufactured by Mylan Pharmaceuticals Inc, Morgantown, WV, 26505, NDC 51079-882-20", "report_date": "20161116", "classification": "Class III", "openfda": {}, "recalling_firm": "Mylan Institutional, Inc. (d.b.a. UDL Laboratories)", "recall_number": "D-0136-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "75295", "termination_date": "20180828", "more_code_info": "", "recall_initiation_date": "20160928", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Charlotte", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82620", "recalling_firm": "CMC Enterprise Pharmacy", "address_1": "4400 Golf Acres Dr", "address_2": "N/A", "postal_code": "28208-5968", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NC", "recall_number": "D-1226-2019", "product_description": "CeFAZolin 3 gm 100 mg/mL, 30 mL syringe, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.", "product_quantity": "475 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190412", "center_classification_date": "20190423", "termination_date": "20191030", "report_date": "20190501", "code_info": "Lots: EB281907 Exp. 4/14/2019; EC011905 Exp. 4/15/2019; EC071907 Exp. 4/21/2019; EC081908 Exp. 4/22/2019; EC131906 Exp. 4/27/2019; EC141906 Exp. 4/28/2019; EC151919 Exp. 4/29/2019; EC181907 Exp. 5/2/2019; EC201906 Exp. 5/4/2019; EC211907 Exp. 5/5/2019; EC221908 Exp. 5/6/2019; EC251907 Exp. 5/9/2019; EC261907 Exp. 5/10/2019; EC271907 Exp. 5/11/2019; EC281907 Exp. 5/12/2019; EC011907 Exp. 5/16/2019; ED021909 Exp. 5/17/2019; ED031907 Exp. 5/18/2019; ED041906 Exp. 5/19/2019; ED051908 Exp. 5/20/2019; ED081907 Exp. 5/23/2019; ED091907 Exp. 5/24/2019"}, {"status": "Terminated", "city": "Waukon", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80963", "recalling_firm": "Beaumont Bio-med, Inc.", "address_1": "21 1st Ave NE", "address_2": "N/A", "postal_code": "52172-1705", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1195-2018", "product_description": "Diarrhea Response Homeopathic Formula, 2 FL. OZ. (59.2 mL) per amber glass oral spray bottle, Distributed by Beaumont Bio-Med, Inc., Waukon, IA 52172; NDC 58066-7022-7", "product_quantity": "160 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20180831", "center_classification_date": "20180917", "termination_date": "20220916", "report_date": "20180926", "code_info": "Lot: 090915A, Exp 09/2018"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "351 ML total", "code_info": "All lots distributed between November 2014 and May 2015;    02232015@75, 5/24/2015; 03042015@22, 6/2/2015; 03172015@44, 6/15/2015; 03192015@21, 6/17/2015; 03232015@61, 6/21/2015; 03272015@49, 6/25/2015; 04132015@50, 7/12/2015; 04132015@54, 7/12/201; 04152015@35, 7/14/2015; 04162015@12, 7/15/2015; 04222015@39, 7/21/2015, 04242015@3, 7/23/2015; 05012015@53, 7/30/2015; 05062015@20, 8/4/2015; 05052015@105, 8/3/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "5-Methy Tetrahydrofolate 5 mg/ml Injectable, Sterile-Multi-Dose Vial, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1432-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA020178"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0553"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807631", "1807632"], "spl_id": ["aca96e4a-a57b-47ac-bd60-e65c29e19743"], "spl_set_id": ["fbc01464-8885-4075-af41-911ffec5ae92"], "package_ndc": ["0338-0553-11", "0338-0553-18"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "68728", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico, Singapore, and Hong Kong", "recall_number": "D-1592-2014", "product_description": "0.9% Sodium Chloride Injection USP MINI-BAG Plus Container, 100 mL VIAFLEX Single Dose Container bags, Rx only, Baxter Healthcare Corporation, Deerfield, IL  60015 USA, NDC 0338-0553-18, Product Code 2B0043.", "product_quantity": "390,560 bags", "reason_for_recall": "Presence of Particulate Matter: particulate matter identified as fibers and/or plastics.", "recall_initiation_date": "20140711", "center_classification_date": "20140918", "termination_date": "20160921", "report_date": "20140924", "code_info": "Lot #: P308650, Exp 10/14", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-743-2015", "product_description": "Ketorolac Tromethamine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "2185 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0962-2023", "product_description": "phenylephrine, 25mg added to 0.9% sodium chloride 250 mL, IV Bag,  Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-7011-1.", "product_quantity": "1,853 bags.", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-249691, 36-249692, Exp. 8/20/2023; 36-250052, 36-250053, Exp. 8/22/2023; 36-251062, Exp. 8/24/2023; 36-251992, Exp. 8/30/2023; 36-252467, Exp. 9/3/2023"}, {"status": "Terminated", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85924", "recalling_firm": "Allergan PLC", "address_1": "2525 Dupont Dr", "address_2": "N/A", "postal_code": "92612-1531", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1409-2020", "product_description": "Skin Medica Acne Treatment Lotion (Benzoyl Peroxide 2.5%), 2 Oz bottle, Distributed in the U.S.A. by Allergan, Irvine, CA 92612, NDC 0023-4965-02", "product_quantity": "4,018 bottles", "reason_for_recall": "SUBPOTENT DRUG: Products failed assay results at the 12 and 24 month timepoints.", "recall_initiation_date": "20200706", "center_classification_date": "20200727", "termination_date": "20240228", "report_date": "20200805", "code_info": "Lot #: 087293, Exp. Date 06/30/2020; 091356, Exp. Date 03/31/2021; Lot #: 093770, 093771, Exp. Date 07/31/2021"}, {"status": "Terminated", "city": "Broomfield", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA064076"], "brand_name": ["AMOXICILLIN"], "generic_name": ["AMOXICILLIN"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0781-2020", "0781-2613", "0781-5060", "0781-5061", "0781-6039", "0781-6156", "0781-6041", "0781-6157"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMOXICILLIN"], "rxcui": ["239191", "308182", "308189", "308191", "308192", "308194", "313797", "313850"], "spl_id": ["6aa02079-d11c-4d2f-acaf-9548dd9a7ed6"], "spl_set_id": ["13bd4214-9b7f-425b-af5f-fc1ddc678230"], "package_ndc": ["0781-2020-31", "0781-2020-76", "0781-2020-01", "0781-2020-05", "0781-2613-31", "0781-2613-76", "0781-2613-01", "0781-2613-05", "0781-5060-20", "0781-5060-01", "0781-5061-20", "0781-5061-01", "0781-6039-58", "0781-6039-46", "0781-6039-55", "0781-6156-52", "0781-6156-57", "0781-6156-46", "0781-6041-58", "0781-6041-46", "0781-6041-55", "0781-6157-52", "0781-6157-57", "0781-6157-46"], "is_original_packager": [true], "upc": ["0307816156526", "0307812020012", "0307816041587", "0307815060015", "0307815061012", "0307816157523", "0307816039584", "0307812613016"], "unii": ["804826J2HU"]}, "product_type": "Drugs", "event_id": "64936", "recalling_firm": "Sandoz Incorporated", "address_1": "2555 W Midway Blvd", "address_2": "", "postal_code": "80020-1632", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-268-2013", "product_description": "Amoxicillin Capsules USP 500 mg, Manufactured in Austria by Sandoz GmbH for Sandoz Inc., Princeton, NJ 08540, Rx only.  Manufactured in 500 ct (NDC 0781-2613-05) and 30 ct (NDC 0781-2613-31) bottles.", "product_quantity": "8286 x 30 ct, 37108 x 500 ct. bottles", "reason_for_recall": "Presence of Foreign Substance, Sandoz is recalling certain lots of Amoxicillin Capsules, USP 500 mg due to potential contamination with fragments of stainless steel wire mesh.", "recall_initiation_date": "20130418", "center_classification_date": "20130423", "termination_date": "20140226", "report_date": "20130501", "code_info": "CK2003, CK2004 exp. 04/15, CR4110, CR4111, CS2983, CS2986, CS2988, CS2989, CS2990, CS2991, CS2992, CS2993, CS2994 exp. 07/15, CK3616, CK3617 exp. 04/15", "more_code_info": ""}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0330-2017", "product_description": "QUAD3 (PAP/PHEN/ALPRO/ATRO) 30 mg/3 mg/30 mcg/0.1mL Injectable, a) 2 mL and 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "a) 1,312 vials and b) 3,354 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.      a) Known lot code: 03292016@12, 0422016@10, 04222016@10, 05052016@33, 05122016@11, 05132016@19, 05242016@2, 06212016@17, 07262016@36, 09072016@21, 09142015@17    b) Known lot code: 03242016@9, 04112016@10, 04212016@19, 05042016@20, 05132016@21, 05202016@71, 06152016@7, 07122016@21, 08032016@17, 09092016@35."}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0108-2019", "product_description": "Woman Power, Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879 NDC 61096-0034-1 and Tester NDC 61096-1034-1", "product_quantity": "1,284 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207687"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-044", "16729-045", "16729-046", "16729-047"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["40828d2e-69eb-5d38-e063-6394a90abd70"], "spl_set_id": ["4e06b20d-cc5d-46eb-991b-5972248de3af"], "package_ndc": ["16729-045-10", "16729-045-15", "16729-045-01", "16729-045-16", "16729-045-17", "16729-044-10", "16729-044-15", "16729-044-01", "16729-044-16", "16729-044-17", "16729-046-10", "16729-046-15", "16729-046-01", "16729-046-16", "16729-046-17", "16729-047-10", "16729-047-15", "16729-047-01", "16729-047-16", "16729-047-17"], "is_original_packager": [true], "unii": ["48A5M73Z4Q"], "upc": ["316729044158", "316729044172"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0371-2023", "product_description": "Atorvastatin Calcium Tablets USP, 10 mg* Rx Only, Packaged as  a) 90 Tablets NDC 16729-044-15 UPC 3 16729 04415 8; b) 1,000 Tablets NDC 16729-044-17 UPC 3 16729 04417 2; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA.", "product_quantity": "256,106 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a)R2100455, Exp. Date 3/31/2023; R2200274, Exp. Date 1/31/2024; R2200700, Exp. Date 5/31/2024;  b) R2101342, R2101343, R2101476, Exp. Date 9/30/2023; R2101364, R2101365, R2101366, R2101367, Exp. Date 10/31/2023; R2101612, R2101613, R2101614, Exp. Date 11/30/2023; R2200222, R2200221, R2200223, Exp. Date 1/31/2024; R2200795, R2200713, R2200701, R2200711, R2200712, R2200756, R2200757, R2200754, R2200755, Exp. Date 5/31/2024; R2200945, R2200943, Exp. Date 6/30/2024;", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0834-2019", "product_description": "Dr. King's SafeCare Rx Acid Clenz, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955012726, NDC 57955-0127-2", "product_quantity": "133 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 050216U Exp. 05/19; 072716C Exp. 07/19"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0082-2016", "product_description": "ESTRADIOL, Injectable Solution, 20 mg/mL, 5 mL\t syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "2 syringes", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t03132015@5, t05182015@21"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077242"], "brand_name": ["GABAPENTIN"], "generic_name": ["GABAPENTIN"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["62756-137", "62756-138", "62756-139", "62756-202", "62756-204"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GABAPENTIN"], "spl_id": ["aff50a15-df39-495f-a145-0ba59660eed8"], "spl_set_id": ["c9a05f0c-b5f0-422c-9d67-6d0efc921a74"], "package_ndc": ["62756-137-02", "62756-137-03", "62756-137-05", "62756-137-04", "62756-137-01", "62756-138-02", "62756-138-03", "62756-138-05", "62756-138-04", "62756-138-01", "62756-139-02", "62756-139-03", "62756-139-05", "62756-139-04", "62756-139-01", "62756-202-01", "62756-202-03", "62756-204-01", "62756-204-03"], "is_original_packager": [true], "upc": ["0362756204010", "0362756202016", "0362756138025", "0362756137028", "0362756139022"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["6CW7F3G59X"]}, "product_type": "Drugs", "event_id": "96415", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0312-2025", "product_description": "Gabapentin Capsules, USP 400 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-139-05; b) 1000-count bottles, NDC 62756-139-04; Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India.", "product_quantity": "852 bottles", "reason_for_recall": "Cross Contamination", "recall_initiation_date": "20250304", "center_classification_date": "20250404", "report_date": "20250416", "code_info": "Lot # a) HAD1712B, Exp. date 03/2025 b) HAD1712C, exp. date 03/2025"}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1218-2020", "product_description": "Bi-Est (8:2)/Progesterone/Testosterone 0.5/75 mg per 0.2 mL Cream 6 mL jar, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 jar", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 44518 Discard by: 3/15/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0237-2020", "product_description": "S-MAGNESIUM CHLORIDE 200MG/ML MDV INJ, 30 ml vial, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:  S07162019DH@15, Exp 8/16/19"}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62511", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distribution was nationwide, including Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-083-2013", "product_description": "Levothroid (levothyroxine sodium tablets, USP), 137 mcg., 100-count bottles, Rx only, NDC 0456-1331-01,   Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "36,978/100-tablet bottles", "reason_for_recall": "cGMP Deviations; does not meet in process specification requirements", "recall_initiation_date": "20120709", "center_classification_date": "20121203", "termination_date": "20131114", "report_date": "20121212", "code_info": "Lot #1095212 exp. 4/30/2013; and #1088877, exp. 11/30/2012"}, {"status": "Ongoing", "city": "Ledgewood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94552", "recalling_firm": "Imprimis NJOF, LLC", "address_1": "1705 Route 46 Ste 6B", "address_2": "N/A", "postal_code": "07852-9720", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "US Nationwide", "recall_number": "D-0548-2024", "product_description": "Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension, 1%, 0.5%, 0.075%, 5mL, Quantity: 20mL, Rx Only, Compounded by: Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ NDC 71384-310-05", "product_quantity": "4,280 boxes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240514", "center_classification_date": "20240607", "report_date": "20240619", "code_info": "Lot: 23NOV018 Exp. 6/17/24"}, {"status": "Terminated", "city": "East Haven", "state": "CT", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "80045", "recalling_firm": "Milbar Laboratories, Inc.", "address_1": "20 Commerce St", "address_2": "N/A", "postal_code": "06512-4145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to physicians and internet sales throughout the United States and Hong Kong, Panama, UK, China, Jordan, Qatar, Kuwait, and Central America.", "recall_number": "D-0832-2018", "product_description": "T Shampoo For Hair and Body, Solution Coal Tar 3% (0.6% coal tar), 300 ml/10.1 fl. oz. bottles, Dermatologic Cosmetic Laboratories, East Haven, CT", "product_quantity": "952 bottles", "reason_for_recall": "Subpotent", "recall_initiation_date": "20180504", "center_classification_date": "20180522", "termination_date": "20190318", "report_date": "20180530", "code_info": "Lot # MT390-8, expiration date 12/01/2020  GU925-4, expiration date 07/05/2020"}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076900"], "brand_name": ["ATENOLOL"], "generic_name": ["ATENOLOL"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-022", "68382-023", "68382-024"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATENOLOL"], "rxcui": ["197379", "197380", "197381"], "spl_id": ["860eb406-b330-4b72-b768-122d57c74293"], "spl_set_id": ["db801706-1362-44c7-92ab-f584f96c7e1c"], "package_ndc": ["68382-022-16", "68382-022-01", "68382-022-10", "68382-022-40", "68382-022-24", "68382-023-16", "68382-023-01", "68382-023-10", "68382-023-02", "68382-023-40", "68382-023-24", "68382-024-16", "68382-024-01", "68382-024-10", "68382-024-40"], "is_original_packager": [true], "nui": ["N0000000161", "N0000175556"], "pharm_class_moa": ["Adrenergic beta-Antagonists [MoA]"], "pharm_class_epc": ["beta-Adrenergic Blocker [EPC]"], "unii": ["50VV3VW0TI"]}, "product_type": "Drugs", "event_id": "76673", "recalling_firm": "Zydus Pharmaceuticals USA Inc", "address_1": "73 Route 31 N", "address_2": "", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico.", "recall_number": "D-0605-2017", "product_description": "ATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b) 1000-count bottles (NDC 68382-023-10), Rx only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ  08534.", "product_quantity": "9561 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.", "recall_initiation_date": "20170306", "center_classification_date": "20170321", "termination_date": "20191105", "report_date": "20170329", "code_info": "Lot #: a) Z600724, Exp 04/18; Z600725, Exp 04/18", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040422"], "brand_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-0775", "0555-0971", "0555-0972", "0555-0776", "0555-0777", "0555-0973", "0555-0974"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "rxcui": ["541363", "541878", "541892", "577957", "577961", "687043", "1009145"], "spl_id": ["88468f3d-7d03-4cee-aabf-3abc8c9b5e38"], "spl_set_id": ["cffbbb15-d776-41ae-a8a6-687f2c07bfa4"], "package_ndc": ["0555-0971-02", "0555-0775-02", "0555-0972-02", "0555-0776-02", "0555-0777-02", "0555-0973-02", "0555-0974-02"], "is_original_packager": [true], "unii": ["JJ768O327N", "O1ZPV620O4", "6DPV8NK46S", "G83415V073"]}, "product_type": "Drugs", "event_id": "85712", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United State and Puerto Rico.", "recall_number": "D-1286-2020", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets ( Mixed Amphetamine Salts Product), 15 mg, 100 count bottles, Rx Only, Teva Pharmaceuticals USA, INC. North Wales, PA 19454, NDC 0555-0777-02", "product_quantity": "41,348 bottles", "reason_for_recall": "Some bottles may contain mixed strengths of the product.", "recall_initiation_date": "20200522", "center_classification_date": "20200604", "termination_date": "20210525", "report_date": "20200610", "code_info": "Lot #: 42617008, Exp. date 10/2021"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-641-2015", "product_description": "Doxycycline HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "38900 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0858-2021", "product_description": "ZTE-105 Formula Gentle Detoxing. Contents 1000 mL, RX Only, REMEDY: Bryoni Alba 10X, Chelidonium Majus 10X, Carduus Marianus 10X, Dolichos Pruriens 10X, Solidago Vigaurea 10X, Alfalfa 10X, Boldo 10X, Cynara Scolymus 10X, Zincum Muriaticum 13X, Chromium Sulphuricum 10X, Manganum Metallicum 10X, Dilution Alcohol 20%. WHP Homeopathic Medicine. For Manufacturing Use Only, Manufactured for Optimal Health Dimensi.  Manufactured By: Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV, 25411.", "product_quantity": "3/1 Liter bottles", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 25950, 26933, Exp 8/17/2026"}, {"status": "Terminated", "city": "North Chicago", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020517"], "brand_name": ["LUPRON DEPOT"], "generic_name": ["LEUPROLIDE ACETATE"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0074-3346", "0074-3473", "0074-3683", "0074-3642"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "spl_id": ["98a4f293-ee7c-44d0-9a1e-9dc7faf8aaf8"], "spl_set_id": ["cbc8f94e-7330-4465-05ad-16d64493a5dd"], "package_ndc": ["0074-3473-03", "0074-3683-03", "0074-3642-03", "0074-3346-03"], "is_original_packager": [true], "upc": ["300743346039"]}, "product_type": "Drugs", "event_id": "67709", "recalling_firm": "AbbVie Inc", "address_1": "1 N Waukegan Rd", "address_2": "", "postal_code": "60064", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1287-2014", "product_description": "Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 22.5 mg for 3-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL  60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3346-03, UPC 3 00743 34603 9.", "product_quantity": "7362 kits", "reason_for_recall": "Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.", "recall_initiation_date": "20140310", "center_classification_date": "20140429", "termination_date": "20160622", "report_date": "20140507", "code_info": "Lot #: 1014204, Exp 10/11/15; 1014485, Exp 12/11/16; and 1015007, Exp 12/06/16", "more_code_info": ""}, {"status": "Ongoing", "city": "Fair Lawn", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91427", "recalling_firm": "Fisher Scientific Co., LLC", "address_1": "1 Reagent Ln", "address_2": "N/A", "postal_code": "07410-2802", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0164-2023", "product_description": "Hand Sanitizer, HSANI4LI, (Isopropyl Alcohol), 75% Topical Solution, packaged in 4 L bottles, Thermo Fisher Scientific: Janssen Pharmaceuticalaan 3a, 2440 Geel - Belgium, 1 Reagent Lane, Fair Lawn, NJ 07410.", "product_quantity": "106 bottles", "reason_for_recall": "CGMP Deviations: Voluntary recall of all hand sanitizer distributed after March 31, 2022, due to FDA issued guidance to cease placing hand sanitizer product, produced under temporary approval, into the market after March 31, 2022.", "recall_initiation_date": "20230117", "center_classification_date": "20230118", "report_date": "20230125", "code_info": "Lot Numbers: 202161, 202322, 202323, 202794, 202858, 203188, 203238, 203240, 203722 203723, 203724, 203725, 204852"}, {"status": "Terminated", "city": "Grand Island", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA088912"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-186"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807632", "1807636", "1807637", "1807638"], "spl_id": ["75c567e3-582b-4fff-9a72-f326f1d13c8f"], "spl_set_id": ["f62481fd-fcdb-4be6-ac13-29c590e925c3"], "package_ndc": ["63323-186-04", "63323-186-02", "63323-186-01", "63323-186-10", "63323-186-03", "63323-186-20"], "is_original_packager": [true], "upc": ["0363323186036"], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "81570", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3159 Staley Rd", "address_2": "N/A", "postal_code": "14072-2028", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA and Puerto RIco", "recall_number": "D-0298-2019", "product_description": "SODIUM CHLORIDE INJECTION, USP, 0.9%, 10 mL Single Dose Vial, packaged in a 25-unit tray, Rx Only, APP Pharmaceuticals, LLC Schaumburg, IL 60173. NDC 63323-186-10 Product code 918610", "product_quantity": "23,745,300 10 mL vials", "reason_for_recall": "Labeling Not Elsewhere Classified: Fresenius Kabi is taking this action due to an incorrect statement on the product insert for product codes 918610 and 918620 indicating that the stoppers do not contain natural rubber latex.  The tray label for these two product codes and the vial label for product code 918620 also incorrectly state that the stoppers do not contain latex.  The above listed product codes and batches being recalled have stoppers containing natural rubber latex.", "recall_initiation_date": "20181115", "center_classification_date": "20181214", "termination_date": "20230501", "report_date": "20181212", "code_info": "Lot#         EXP date:  6013112 11/2018  6013113 11/2018  6013114 11/2018  6013180 11/2018  6013181 11/2018  6013182 11/2018  6013237 01/2019  6013238 01/2019  6013239 01/2019  6013468 02/2019  6013512 02/2019  6013513 02/2019  6013551 02/2019  6013552 02/2019  6013553 02/2019  6013607 02/2019  6013608 02/2019  6013610 02/2019  6013627 03/2019  6013678 03/2019  6013679 03/2019  6013822 03/2019  6013823 03/2019  6013824 03/2019  6013924 04/2019  6013925 04/2019  6013926 04/2019  6014003 05/2019  6014004 05/2019  6014005 05/2019  6014260 05/2019  6014301 05/2019  6014302 05/2019  6014303 06/2019  6014304 06/2019  6014305 06/2019  6014306 06/2019  6014307 06/2019  6014384 06/2019  6014404 06/2019  6014405 06/2019  6014453 06/2019  6014454 06/2019  6014455 06/2019  6014479 06/2019  6014557 07/2019  6014558 07/2019  6014606 07/2019  6014649 08/2019  6014650 08/2019  6014704 08/2019  6014766 08/2019  6014767 08/2019  6014768 08/2019  6014841 08/2019  6014842 08/2019  6014843 08/2019  6014861 08/2019  6014862 08/2019  6014863 08/2019  6015049 09/2019  6015050 09/2019  6015088 09/2019  6015118 10/2019  6015127 10/2019  6015128 10/2019  6015186 10/2019  6015187 10/2019  6015188 10/2019  6015233 10/2019  6015234 10/2019  6015235 10/2019  6015285 11/2019  6015286 11/2019  6015287 11/2019  6015408 11/2019  6015409 11/2019  6015410 11/2019  6015452 11/2019  6015453 11/2019  6015454 11/2019  6015572 11/2019  6015573 12/2019  6015574 12/2019  6015616 12/2019  6015617 12/2019  6015618 12/2019  6015922 01/2020  6015923 01/2020  6015924 01/2020  6016002 02/2020  6016003 02/2020  6016004 02/2020  6016077 02/2020  6016104 02/2020  6016208 02/2020  6016209 02/2020  6016210 02/2020  6016258 02/2020  6016259 02/2020  6016260 02/2020  6016261 02/2020  6016262 03/2020  6016263 03/2020  6016264 03/2020  6016323 03/2020  6016324 03/2020  6016325 03/2020  6016383 03/2020  6016384 03/2020  6016385 03/2020  6016386 03/2020  6016387 03/2020  6016388 03/2020  6016389 03/2020  6016584 04/2020  6016585 04/2020  6016621 04/2020  6016622 04/2020  6016623 04/2020  6016765 05/2020  6016766 05/2020  6016767 05/2020  6016768 05/2020  6016769 05/2020  6016875 06/2020  6016876 06/2020  6016877 06/2020  6016878 06/2020  6016879 06/2020  6017288 06/2020  6017289 06/2020  6017290 06/2020  6017291 06/2020  6017382 07/2020  6017425 07/2020  6017426 07/2020  6017427 07/2020  6017428 07/2020  6017429 07/2020  6017470 07/2020  6017471 07/2020  6017472 07/2020  6017473 07/2020  6017474 07/2020  6017675 08/2020  6017725 08/2020  6017726 08/2020  6013062 11/2018  6014162 05/2019  6014163 05/2019  6014164 05/2019  6014377 06/2019  6014378 06/2019  6014379 06/2019  6016005 02/2020  6016071 02/2020  6016072 02/2020  6016073 02/2020  6017383 07/2020  6017384 07/2020  6017422 07/2020  6017423 07/2020  6017424 07/2020    non US  6013112 11/2018  6013113 11/2018  6013114 11/2018  6013180 11/2018  6013181 11/2018  6013182 11/2018  6013237 01/2019  6013238 01/2019  6013239 01/2019  6013468 02/2019  6013512 02/2019  6013513 02/2019  6013551 02/2019  6013552 02/2019  6013553 02/2019  6013607 02/2019  6013608 02/2019  6013610 02/2019  6013627 03/2019  6013678 03/2019  6013679 03/2019  6013822 03/2019  6013823 03/2019  6013824 03/2019  6013924 04/2019  6013925 04/2019  6013926 04/2019  6014003 05/2019  6014004 05/2019  6014005 05/2019  6014260 05/2019  6014301 05/2019  6014302 05/2019  6014303 06/2019  6014304 06/2019  6014305 06/2019  6014306 06/2019  6014307 06/2019  6014384 06/2019  6014404 06/2019  6014405 06/2019  6014453 06/2019  6014454 06/2019  6014455 06/2019  6014479 06/2019  6014557 07/2019  6014558 07/2019  6014606 07/2019  6014649 08/2019  6014650 08/2019  6014704 08/2019  6014766 08/2019  6014767 08/2019  6014768 08/2019  6014841 08/2019  6014842 08/2019  6014843 08/2019  6014861 08/2019  6014862 08/2019  6014863 08/2019  6015049 09/2019  6015050 09/2019  6015088 09/2019  6016209 02/2020  6016210 02/2020  6016258 02/2020  6016259 02/2020  6016260 02/2020  6016261 02/2020  6016262 03/2020  6016263 03/2020  6016264 03/2020  6016323 03/2020  6016324 03/2020  6016325 03/2020  6016383 03/2020  6016384 03/2020  6016385 03/2020  6016386 03/2020  6016387 03/2020  6016388 03/2020  6016389 03/2020  6016584 04/2020  6016585 04/2020  6016621 04/2020  6016622 04/2020  6016623 04/2020  6016765 05/2020  6016766 05/2020  6016767 05/2020  6016768 05/2020  6016769 05/2020  6016875 06/2020  6016876 06/2020  6016877 06/2020  6016878 06/2020  6016879 06/2020  6017288 06/2020  6017289 06/2020  6017290 06/2020  6017291 06/2020  6017382 07/2020  6017425 07/2020  6017426 07/2020  6017427 07/2020  6017428 07/2020  6017429 07/2020  6017470 07/2020  6017471 07/2020  6017472 07/2020  6017473 07/2020  6017474 07/2020  6017675 08/2020  6017726 08/2020"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "75300", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0111-2017", "product_description": "PARICALCITOL Capsules, 4 mcg, 30-count bottles, Rx only, Manufactured By: Pharmaceutics International, Inc., Hunt Vallet, MD  21031; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA  19454, NDC 0093-7658-56.", "product_quantity": "5,398 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: out of specification test results for impurities during stability testing.", "recall_initiation_date": "20160922", "center_classification_date": "20161019", "termination_date": "20170505", "report_date": "20161026", "code_info": "Lot #: 13010.006A, Exp  09/16; 13010.007A, Exp 05/17"}, {"status": "Terminated", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76407", "recalling_firm": "Cherry Hill Sales Co.", "address_1": "1115 Eden Way N", "address_2": "N/A", "postal_code": "23320-2751", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Michigan, Illinois, New York, Florida, Pennsylvania .", "recall_number": "D-0483-2017", "product_description": "MakeSense PHARMA, HEMORRHOIDAL RELIEF CREAM Phenylephrine HCL-0.25% Zinc Oxide-12.50%,1 oz. (28 g) tube, Made in China, Distributed by Cherry Hill Associates, Chesapeake, VA 23320, NDC 69020-205-28", "product_quantity": "3,600 cartons", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20170127", "center_classification_date": "20170218", "termination_date": "20170419", "report_date": "20170301", "code_info": "Lot #103811;  Exp. 09/17  Lot #105304;  Exp. 04/18  NDC 69020-205-28  UPC 857181005108"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0135-2015", "product_description": "Sodium tetradecyl sulfate 3% (PF) injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL..", "product_quantity": "72 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08062014@31, Exp 9/5/2014; 08112014@47, Exp 9/10/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1361-2016", "product_description": "0.05 mg/mL Morphine Sulfate and 0.0625% Bupivacaine HCI (Preservative Free) in 0.9% Sodium Chloride, 250 mL Hospira LifeCare bag, Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-995-54\t\t,", "product_quantity": "80 bags", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Lot # 160420165M; Exp. 05/16   Lot # 160540128M; Exp. 05/16   Lot # 160630117M; Exp. 06/16   Lot # 160770157M; Exp. 06/16   Lot # 160870055M; Exp. 06/16   Lot # 160890153M; Exp. 06/16  Lot # 160950340M; Exp. 07/16", "more_code_info": ""}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78552", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0096-2018", "product_description": "Clozapine Tablets USP, 100 mg, 500 count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICALS IND, LTD, Jerusalem Israel, Manufactured For: TEVA PHARMACEUTICALS USA, North Wales, PA, NDC 00093-7772-05", "product_quantity": "3,870 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications; potential presence of broken tablets.", "recall_initiation_date": "20171109", "center_classification_date": "20171127", "termination_date": "20180703", "report_date": "20171206", "code_info": "Lot # 39C192, exp 06/2019"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0571-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Hemorrhoid Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955502326, NDC 57955-5023-2", "product_quantity": "2045 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 012317C Exp. 01/20; 052516U Exp. 05/19; 050216S Exp. 05/19"}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1 container", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Sal-Acid 60% Plaster Paste, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0449-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0795-2023", "product_description": "Clobetasol Propionate Ointment, USP, 0.05%, 15 g tubes, Rx Only, Distributed by: Akorn Operating Company, LLC., Gurnee, IL 60031.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64481", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-243-2013", "product_description": "0.9% Sodium Chloride Injection, USP, 50 mL, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7984-36    Hospira, Inc., Lake Forest, IL 60045", "product_quantity": "624,240 units", "reason_for_recall": "Lack of Assurance of Sterility: The product is being recall due to the product lot being incorrectly released without meeting product specifications. There is the potential for the solution to leak from the administrative port to the fill tube seal.", "recall_initiation_date": "20130218", "center_classification_date": "20130404", "termination_date": "20150406", "report_date": "20130410", "code_info": "Lot #: 22-028-JT Exp 04/14"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "1 vial", "code_info": "Lot # t02-15-2017@111, Exp 4/30/2017.", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "HYDROXO-B12 5ML PBF MDV (CALIF) 10MG/ML INJ, Injection, 10mg/mL, RX only, 5mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0728-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "97370", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0578-2025", "product_description": "Carvedilol Tablets, USP, 12.5 mg, 500-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd, Colvale-Bardez, Goa, 403513, India. Manufactured for Glenmark Pharmaceuticals, Inc., USA, Mahwah, NJ 07430. NDC 68462-164-05", "product_quantity": "6,432 bottles", "reason_for_recall": "CGMP Deviations: Presence of a nitrosamine,  N-Nitroso Carvedilol I  Impurity above the current Acceptable Intake Level.", "recall_initiation_date": "20250807", "center_classification_date": "20250812", "report_date": "20250820", "code_info": "Lot#:19243202, Exp: 7/31/2026.", "more_code_info": ""}, {"status": "Terminated", "city": "Sunset", "state": "LA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70085", "recalling_firm": "Jaymac Pharmaceuticals L.L.C.", "address_1": "2085 I49 South Service Road", "address_2": "N/A", "postal_code": "70584", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S. including: LA, AR, TX, MS", "recall_number": "D-0327-2015", "product_description": "J-TAN D PD Drops (bromphenirame maleate 1 mg and pseudoephedrine hcl 7.5 mg/ teaspoon), 1 fl oz (30 mL) Bottle, Over the Counter. Manufactured for JayMac Pharmaceuticals, LLC, Sunset, LA; Manufactured by Sonar Products Inc., Carlstadt, NJ, NDC: 64661-032-30.", "product_quantity": "5572 Bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified: Product is labeled \"Dye Free\" on front panel but contains Red Dye 40.", "recall_initiation_date": "20141216", "center_classification_date": "20141229", "termination_date": "20150601", "report_date": "20150107", "code_info": "Lot #: 7770, Expiry: 02/16"}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90512", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1279-2022", "product_description": "8.4% Sodium Bicarbonate Injection, USP, 4.2 g/50 mL (84 mg/mL) 1 mEq/mL syringe, packaged in 1 x 50 mL Pre-Filled Syringe per carton, 30 x 1 syringe carton per case, Rx Only Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-214-50", "product_quantity": "36,354 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220630", "center_classification_date": "20220718", "termination_date": "20240617", "report_date": "20220727", "code_info": "Lots: SB2001B, Exp. 1/2/2023; SB2001C, Exp. 1/2/2023; SB2003A, Exp. 2/14/2023; SB2003B, Exp. 2/14/2023; SB2003C, Exp. 2/14/2023; SB2004A, Exp. 3/1/2023; SB2004B, Exp. 3/1/2023; SB2004C, Exp. 3/1/2023; SB2005A, Exp. 3/8/2023; SB2007A, Exp. 3/22/2023; SB2007B, Exp. 3/22/2023; SB2008A, Exp. 3/29/2023; SB2008B, Exp. 3/29/2023; SB2009A, Exp. 4/5/2023; SB2009B, Exp. 4/5/2023"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "82092", "recalling_firm": "Akorn Inc", "address_1": "1925 W Field Ct Ste 300", "address_2": "", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, including Puerto Rico.", "recall_number": "D-0515-2019", "product_description": "Clobetasol Propionate Emollient Cream 0.05%, a) 30 gram (NDC 50383-270-30) and b) 60 gram (NDC 50383-270-60) tubes, Rx only. Manufacturer: Akorn Inc. 369 Bayview Ave., Amityville, NY 117701.", "product_quantity": "a) 4896 tubes; b) 5064 tubes", "reason_for_recall": "Failed Stability Specification; out of specification (OOS) results for a preservative at 9 month stability study.", "recall_initiation_date": "20190125", "center_classification_date": "20190220", "termination_date": "20201103", "report_date": "20190227", "code_info": "a) 357052, exp 4/19/19  b) 356892, exp 4/16/19 and 356927, exp 4/15/19", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78063", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-0041-2018", "product_description": "Oxytocin 20 units added to 500 mL Lactated Ringer's Injection USP in 500 mL bag Rx Only, Compounded by PharMEDium Services, LLC. 12620 W. Airport Blvd. #130 Sugar Land, TX 77478, NDC# 71019-241-03", "product_quantity": "60 bags", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20170901", "center_classification_date": "20171025", "termination_date": "20200124", "report_date": "20171101", "code_info": "All unexpired lots."}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "4 vials", "code_info": "Lot # t12-12-2016@93, Exp 5/22/2017; t02-22-2017@93, Exp 8/2/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "TRI MIX 5.95/17.8572/0.6 5ML MDV MCG/MG/MG/ML INJ, Injection, 5.95mcg/17.85mg/0.6mg/mL,  Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0751-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0089-2016", "product_description": "ETHYL ALCOHOL (STERILE FOR INJECTION) 100%, Injectable Solution, 200 PROOF, 30 mL syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "1 syringe", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t05192015@11"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; FINASTERIDE, Tablet, 5 mg may be potentially mislabeled as    DIGOXIN, Tablet, 0.125 mg, NDC 00115981101, Pedigree: AD62829_8, EXP: 5/23/2014;  PHYTONADIONE, Tablet, 5 mg, NDC 25010040515, Pedigree: W003061, EXP: 5/31/2014.", "address_2": "", "product_quantity": "120 Tablets", "code_info": "FINASTERIDE Tablet, 5 mg has the following codes    Pedigree: AD62846_1, EXP: 2/28/2014;  Pedigree: W003031, EXP: 2/28/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "FINASTERIDE Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714052201", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-519-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1431-2016", "product_description": "5 mcg/mL HYDROmorphone HCl and 0.125% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 50 mL in 60 mL BD Syringe, Service Code 2T6197, Rx Only,  Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-197-20", "product_quantity": "5 syringes", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Lot Number 160540183M , Exp. Date 5/23/2016", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0280-2021", "product_description": "Epoprostenol Sodium for Injection, 1.5 mg/vial (1,500,000 ng), 10 mL vial, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA  19454, NDC 0703-1995-01.", "product_quantity": "12,609 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot # 31326456B, exp. date 02/28/2021"}, {"status": "Terminated", "city": "Waco", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74126", "recalling_firm": "Allergan Sales, LLC", "address_1": "8301 Mars Dr", "address_2": "N/A", "postal_code": "76712-6578", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1064-2016", "product_description": "Tazorac (tazarotene) Gel 0.05%, Rx only, packaged in a) 30g (NDC 0023-8335-03) and b) 100g (NDC 0023-8335-10) tubes, Allergan Inc, Irvine, CA 92612", "product_quantity": "17802 units", "reason_for_recall": "Failed Content Uniformity Specifications.", "recall_initiation_date": "20160510", "center_classification_date": "20160706", "termination_date": "20171206", "report_date": "20160713", "code_info": "Lot #: a) 84172, b) 84173, Exp FEB/2017"}, {"status": "Terminated", "city": "Lexington", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA020049"], "brand_name": ["PENTASA"], "generic_name": ["MESALAMINE"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "product_ndc": ["54092-189", "54092-191"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MESALAMINE"], "rxcui": ["206791", "314092", "476362", "580286"], "spl_id": ["42661699-8fcc-40da-a05d-91906f9973e8"], "spl_set_id": ["e39d9a3d-5d3a-4bb6-aab1-fdbb2a598606"], "package_ndc": ["54092-189-81", "54092-191-12"], "is_original_packager": [true], "upc": ["0354092191123", "0354092189816"], "nui": ["N0000175781", "M0000971"], "pharm_class_epc": ["Aminosalicylate [EPC]"], "pharm_class_cs": ["Aminosalicylic Acids [CS]"], "unii": ["4Q81I59GXC"]}, "product_type": "Drugs", "event_id": "75880", "recalling_firm": "Shire PLC", "address_1": "300 Shire Way", "address_2": "", "postal_code": "02421-2101", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0432-2017", "product_description": "Pentasa (mesalamine) Controlled-Release Capsules, 250 mg, 240 count bottle, Rx only, Manufactured for Shire US Inc., Lexington, MA --- NDC 54092-189-81", "product_quantity": "4,520 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules; 500 mg capsules were found in bottles labeled to contain 250 mg capsules", "recall_initiation_date": "20161202", "center_classification_date": "20170117", "termination_date": "20180601", "report_date": "20170125", "code_info": "Lot Number AE7363A, exp 06/30/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA073135"], "brand_name": ["METOCLOPRAMIDE"], "generic_name": ["METOCLOPRAMIDE"], "manufacturer_name": ["Teva Parenteral Medicines, Inc."], "product_ndc": ["0703-4502"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["METOCLOPRAMIDE HYDROCHLORIDE"], "rxcui": ["311670"], "spl_id": ["e640a87c-7ee3-4ca2-9808-3916bfd1a54b"], "spl_set_id": ["cccf04bd-7463-40b8-a41f-cb1093c358d7"], "package_ndc": ["0703-4502-01", "0703-4502-04"], "is_original_packager": [true], "unii": ["W1792A2RVD"]}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0277-2021", "product_description": "Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial NDC 0703-4502-01), packaged in 25 x 2 mL Single-Use Vials per tray (NDC 0703-4502-04), Rx only, Teva Parenteral Medicines, Inc., Irvine, CA  92618.", "product_quantity": "29,357 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot #   31325042B, exp. date 06/2021  31325336B, exp. date  07/2021  31326042B, exp. date  10/2021  31326137B, exp. date  11/2021  31326230B, exp. date  12/2021  31323816B, exp. date  02/2021"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207068"], "brand_name": ["PRAVASTATIN SODIUM"], "generic_name": ["PRAVASTATIN SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-008", "16729-009", "16729-010", "16729-011"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRAVASTATIN SODIUM"], "rxcui": ["904458", "904467", "904475", "904481"], "spl_id": ["0e03244d-61de-bb5f-e063-6294a90a671c"], "spl_set_id": ["6c011348-a236-47d3-bbef-3e0b956dd080"], "package_ndc": ["16729-008-15", "16729-008-16", "16729-008-17", "16729-009-15", "16729-009-16", "16729-009-17", "16729-010-15", "16729-010-16", "16729-010-17", "16729-011-15", "16729-011-16", "16729-011-17"], "is_original_packager": [true], "unii": ["3M8608UQ61"], "upc": ["316729011150"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0424-2023", "product_description": "Pravastatin Sodium Tablets USP, 80 mg, Rx Only, 90- count bottle, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA, NDC 16729-011-15, UPC 3 16729 01115 0", "product_quantity": "1970 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches:  R2201233, Exp. Date 4/30/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Fort Lee", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87641", "recalling_firm": "Nuri Trading LLC", "address_1": "800 Palisade Ave", "address_2": "N/A", "postal_code": "07024-4193", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0685-2021", "product_description": "Shogun-X 7000 capsule, packaged in a) 1-count blister card and b) 10-count box, Nuri Trading LLC", "product_quantity": "N/A", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Product found to be tainted with undeclared tadalafil and sildenafil, two FDA approved drugs making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.", "recall_initiation_date": "20210329", "center_classification_date": "20210719", "report_date": "20210728", "code_info": "all lots within expiry", "more_code_info": ""}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0467-2022", "product_description": "Maximum Strength Non Aspirin Pain Reliever/Fever Reducer (acetaminophen 500 mg) 2 tablet packets, Mfg. for: Advanced First Aid, Baltimore MD 21237, American Safety & First Aid, Osceola, IN 46561, NDC 67060-210-68", "product_quantity": "1,236,000 packets", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: AK9495, Exp. Date 02/2022; AK9613, Exp. Date 05/2022"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0306-2017", "product_description": "Testosterone Suspension 100 mg/mL, (5 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "13 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 06292016C (10/28/2016)."}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077690"], "brand_name": ["QUINAPRIL"], "generic_name": ["QUINAPRIL"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-554", "68180-556", "68180-557", "68180-558", "68180-559"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["QUINAPRIL HYDROCHLORIDE"], "rxcui": ["312748", "312749", "312750", "314203"], "spl_id": ["a9598a21-6f99-4c86-ace6-b5638da2bec8"], "spl_set_id": ["8ded0773-3aec-4e89-9836-d22a5a84abf0"], "package_ndc": ["68180-556-09", "68180-557-09", "68180-557-03", "68180-558-09", "68180-558-03", "68180-554-09", "68180-554-03", "68180-559-03", "68180-559-09"], "is_original_packager": [true], "upc": ["0368180559092", "0368180556091"], "unii": ["33067B3N2M"]}, "product_type": "Drugs", "event_id": "66345", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21st", "address_2": "", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-409-2014", "product_description": "Quinapril Tablets USP, 10 mg, 90 count bottle,  Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202 United States Manufactured by: Lupin Limited Goa 403 722 INDIA, NDC 68180-557-09", "product_quantity": "22, 896 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: During stability testing an unknown impurity was found to be above the specification limit at 36 month test interval", "recall_initiation_date": "20130917", "center_classification_date": "20140110", "termination_date": "20160511", "report_date": "20140122", "code_info": "Lot 3110358 Exp. 12/13", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "51 ml total", "code_info": "All lots distributed between November 2014 and May 2015;  04292015@41, 6/28/2015; 05052015@80, 7/4/2015; 05062015@51, 7/5/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "HCG 2,000 IU/ml Injection, Multi-Dose Vial, Sterile, Refrigerate The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1521-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: TERAZOSIN HCL, Capsule, 5 mg may have potentially been mislabeled as the following drug:  DOXAZOSIN MESYLATE, Tablet, 1 mg, NDC 00093812001, Pedigree: W003912, EXP: 6/28/2014.", "address_2": "", "product_quantity": "100 Capsules", "code_info": "TERAZOSIN HCL, Capsule, 5 mg has the following codes:   Pedigree: W003913, EXP: 6/28/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "TERAZOSIN HCL, Capsule, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781205301.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-1004-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "North Brunswick", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077153"], "brand_name": ["ALLERGY RELIEF"], "generic_name": ["LORATADINE"], "manufacturer_name": ["Ohm Laboratories Inc."], "product_ndc": ["51660-527"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["LORATADINE"], "rxcui": ["311373"], "spl_id": ["7b87d8ea-1102-4642-8a39-b2504dbda716"], "spl_set_id": ["de3a7725-5d1b-4195-a9f8-43f92888997c"], "package_ndc": ["51660-527-31", "5166052731"], "is_original_packager": [true], "unii": ["7AJO3BO7QN"], "upc": ["351660527315"]}, "product_type": "Drugs", "event_id": "71973", "recalling_firm": "Ohm Laboratories, Inc.", "address_1": "1385 Livingston Ave", "address_2": "N/A", "postal_code": "08902-1829", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0032-2016", "product_description": "Ohm Loratadine Orally Disintegrating Tablets, USP, 10 mg, 30-count tablets, Distributed by Ohm Laboratories, Inc. 1385 Livingston Avenue, North Brunswick, NJ 08902, NDC 51660-527-31, UPC 3 5166052731 5", "product_quantity": "311 boxes", "reason_for_recall": "Superpotent Drug: Out Of Specification (OOS) result for Assay.", "recall_initiation_date": "20150728", "center_classification_date": "20151015", "termination_date": "20161028", "report_date": "20151021", "code_info": "Batch Numbers: 2544486, Exp 7/31/2016; 2617891, Exp 5/31/2016;  2644272, Exp 9/30/2016"}, {"status": "Terminated", "city": "Roseburg", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81883", "recalling_firm": "Hiers Enterprises, LLC dba Northwest Compounding Pharmacy", "address_1": "1350 Ne Stephens St Ste 42", "address_2": "N/A", "postal_code": "97470-6410", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients.    These are compounded products - labels vary for each compound - specific to each patient.  Firm did not provide labeling.", "recall_number": "D-0400-2019", "product_description": "Methocarbamol liquid 100mg/ml, RX, glass vial", "product_quantity": "300 ml", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190102", "center_classification_date": "20190127", "termination_date": "20230328", "report_date": "20190109", "code_info": "10082018@34 exp 1/6/19,    10312018@27 exp 1/29/19"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83437", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the United States and Brazil and on the internet", "recall_number": "D-1595-2019", "product_description": "Dragon Pain Oil, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.", "recall_initiation_date": "20190712", "center_classification_date": "20190802", "termination_date": "20230613", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211222"], "brand_name": ["STERILE WATER"], "generic_name": ["STERILE WATER"], "manufacturer_name": ["Nephron Pharmaceuticals Corporation"], "product_ndc": ["0487-6105"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["WATER"], "spl_id": ["39ada97d-53b0-5144-e063-6294a90a91ba"], "spl_set_id": ["bc04a883-babc-87a6-e053-2995a90a3dfd"], "package_ndc": ["0487-6105-01"], "is_original_packager": [true], "upc": ["0304876105013"], "unii": ["059QF0KO0R"]}, "product_type": "Drugs", "event_id": "91767", "recalling_firm": "Nephron Sc Inc", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States", "recall_number": "D-0364-2023", "product_description": "Sterile Water for Injection, USP, 30x5 mL Single-Dose Vials, Rx Only, Nephron 4500 12th Street Extension West Columbia, SC 29172, NDC 0487-6105-01", "product_quantity": "325,080 vials", "reason_for_recall": "CGMP Deviations: Potential product carryover.", "recall_initiation_date": "20230223", "center_classification_date": "20230301", "termination_date": "20241011", "report_date": "20230308", "code_info": "Lot #: 224011, 224021, 224022, 224023 Exp 12/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77780", "recalling_firm": "Cantrell Drug Company", "address_1": "7321 Cantrell Rd", "address_2": "N/A", "postal_code": "72207-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the US", "recall_number": "D-1078-2017", "product_description": "Neostigmine Methylsulfate Injection Solution 5 mL, 5 mg/5 mL (1 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd. Little Rock, AR 72207 877-666-5222, NDC 52533-046-15", "product_quantity": "120856 syringes", "reason_for_recall": "Lack of Sterility Assurance.", "recall_initiation_date": "20170714", "center_classification_date": "20170809", "termination_date": "20200916", "report_date": "20170816", "code_info": "Lot #: 10081, BUD: 7/25/2017; 10096, BUD: 7/27/2017; 10112, BUD: 7/30/2017; 10117, BUD: 7/31/2017; 10152, BUD: 8/3/2017; 10159, BUD: 8/6/2017; 10170, BUD: 8/7/2017; 10174, BUD: 8/8/2017; 10193, BUD: 8/9/2017; 10202, BUD: 8/10/2017; 10212, BUD: 8/13/2017; 10242, BUD: 8/15/2017; 10276, BUD: 8/17/2017; 10294, BUD: 8/20/2017; 10320, BUD: 8/23/2017; 10328, BUD: 8/24/2017; 10334, BUD: 8/28/2017; 10342, BUD: 8/29/2017; 10364, BUD: 9/3/2017; 10392, BUD: 9/6/2017; 10420, BUD: 9/11/2017; 10427, BUD: 9/12/2017; 10440, BUD: 9/14/2017; 10463, BUD: 9/18/2017; 10495, BUD: 9/22/2017; 10499, BUD: 9/24/2017; 10512, BUD: 9/25/2017; 10556, BUD: 10/1/2017; 10567, BUD: 10/3/2017; 10583, BUD: 10/6/2017"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA088325"], "brand_name": ["LIDOCAINE HYDROCHLORIDE"], "generic_name": ["LIDOCAINE HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-4275", "0409-4713", "0409-4278", "0409-4279", "0409-4776", "0409-4282", "0409-4277", "0409-4276"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INFILTRATION", "PERINEURAL"], "substance_name": ["LIDOCAINE HYDROCHLORIDE"], "rxcui": ["1010033", "1010671", "1010900", "1737343", "1737562", "1737566", "1737568", "1737636", "1737757", "1737763"], "spl_id": ["d0322a93-069a-453f-89eb-e5d5559ed075"], "spl_set_id": ["3b2dd84e-cee8-4e58-d494-395a65a353a0"], "package_ndc": ["0409-4713-12", "0409-4713-26", "0409-4713-02", "0409-4713-72", "0409-4713-62", "0409-4713-75", "0409-4713-65", "0409-4713-42", "0409-4713-25", "0409-4713-32", "0409-4278-16", "0409-4278-01", "0409-4279-16", "0409-4279-02", "0409-4776-10", "0409-4776-01", "0409-4282-11", "0409-4282-25", "0409-4282-01", "0409-4282-12", "0409-4282-02", "0409-4277-16", "0409-4277-01", "0409-4277-17", "0409-4277-02", "0409-4276-16", "0409-4276-01", "0409-4276-17", "0409-4276-02", "0409-4275-16", "0409-4275-01"], "is_original_packager": [true], "unii": ["V13007Z41A"]}, "product_type": "Drugs", "event_id": "66441", "recalling_firm": "Hospira, Inc.", "address_1": "600 N Field Dr Bldg J45", "address_2": "N/A", "postal_code": "60045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1234-2014", "product_description": "1% Lidocaine HCl Injection, USP, 10 mg/mL, NDC 0409-4276-01, Hospira, Inc., Lake Forest, IL 60045.", "product_quantity": "374,500 vials", "reason_for_recall": "Presence of Particulate Matter: Oxidized stainless steel found in vial of 1% Lidocaine Hydrochloride Injection, USP.", "recall_initiation_date": "20130916", "center_classification_date": "20140414", "termination_date": "20141104", "report_date": "20140423", "code_info": "Lot #25090DK; Exp 01/15"}, {"status": "Terminated", "city": "Research Triangle Park", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67892", "recalling_firm": "United Therapeutics Corp.", "address_1": "55 Tw Alexander Dr", "address_2": "P.O. Box 14186", "postal_code": "27709-0152", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Fl, TX.", "recall_number": "D-1423-2014", "product_description": "Tyvaso (treprostinil) Inhalation Solution, Treprostinil 1.74 mg/2.9 mL, Four 2.9 mL Ampules, For Oral Inhalation Use Only, Manufactured for United Therapeutics Corporation, Triangle Park, NC 27709", "product_quantity": "188 Units", "reason_for_recall": "Defective Delivery System: United Therapeutics is voluntarily recalling a small number of Tyvaso Inhalation Systems with Optineb ON-100/7 and TD-100/A medical devices. These devices may have been programmed with a different software version than intended for the device. If the device has the incorrect software, it may not operate as indicated in the Instructions for Use.", "recall_initiation_date": "20140328", "center_classification_date": "20140707", "termination_date": "20141024", "report_date": "20140716", "code_info": "Lot #s:   TD-100: PCBA Lot 60  TD-100: PCBA Lot 61  TD-100: PCBA Lot 62  TD-100: PCBA Lot 63  Optineb: PCBA Lot 72  Optineb: PCBA Lot 73    SERIAL NUMBERS:    Kit S/N  ML 1897  ML 1898  ML 1894  ML 1895  ML 1896    TD-100 S/N's   23103954 23103976 23104015 23104017 23104006   23104000 23103995  23104018 23104016    Optineb devices shipped to Caremark:  Kit S/N  ML 3660  MP 3662  ML 3665  MP 3667  MP 3668  MP 3676  MP 3683  MP 3690  ML 3691  MP 3692    Optineb S/N's   20900207 20900212 20900219 20900222 20900226  20900209 20900213  20900225 20900227     20900241 20900310 20900295 20900293 20900291                      20900240 20900308 20900294 20900292 20900290    Kit S/N 3697  MP 3698  ML 3699  MP 3700  MP 3708  MP  Optineb S/N's     20900262 20900283 20900285 20900265 20900253   20900264 20900284 20900286 20900268 20900315    NPR \u0013 Device Not Part of Recall  MP=Mount Prospect; ML-Monroeville    TD-100 devices shipped to Accredo:  Kit S/N   1879 1880 1881 1882 1883 1884 1885 1886 1887  TD-100 S/N's     23103982 23103985 23103988 23103990 23103992  23103984 23103986 23103989 23103991 23103993     23103959 23103961 23103963 23103994                      23103958 23103960 23103962 23103972    Kit S/N                       1888 1889 1890 1891 1892 1893 1899 1900 1901  TD-100 S/N's   23103970 23103997 23103996 23104022 23104019  23103975 23103998 23103999 23104024 23104020     23104014 23103981 23103980 23103974                      23104013 23103978 23103973 23103964    Kit S/N   1902 1903 1904 1905 1906 1907 1908 1909 1910  TD-100 S/N's     23103966 23103968 23103956 23103952 23103950  23103967 23103977 23103957 23103955 23103951     23103948 23103945 23103941                       23103943 23103942 23103940 23103944    Kit S/N   1911 1912 1913 1914 1916 1917 1918 1919 1921  TD-100 S/N's   23103947 23103949 23103939 23103946 23104001   23103965 23103969  23104002     23104005                       23104003 23104011 23104007 23104008    TD-100 devices shipped to Accredo (continued):    Kit S/N   1922 1923 1933 1934  TD-100 S/N's   23104012 23104009 23103937 23103938   23104025 23104010     Kit S/N   1935 1939 2175 2176 2178 2212 2227 2228  TD-100 S/N's   23104030 23104027 23101851 23103987 23103971   23104028   23103700     23103608 23103979 23103334                      23103439 23101566 23103672    Kit S/N   2229 2311 2364 2481 2491  TD-100 S/N's   23103686 23103684 23104026 23104029 23104004      \u0003    Optineb devices shipped to Accredo:  Kit S/N   3658 3659 3661 3669 3670 3672 3674 3675 3680  Optineb S/N's   20900203 20900205 20900210 20900228 20900230  20900204 20900206 20900211 20900229 20900231 20900235 20900223 20900239 20900252                      20900236 20900202 20900224 20900250    Kit S/N   3681 3682 3687 3694 3696 3702 3703 3704  Optineb S/N's   20900249 20900311 20900298 20900256 20900260  20900254 20900312 20900300 20900257 20900261 20900273 20900275 20900277                      20900272 20900274 20900276      Optineb devices shipped to Curascript:  Kit S/N 3657 3666 3671 3673 3677 3679 3685 3686 3689  Optineb S/N's   20900200 20900220 20900232 20900237 20900242  20900201 20900221 20900234 20900238 20900243 20900247 20900305 20900302 20900297                      20900246 20900304 20900301 20900296    Kit S/N 3693 3701 3706 3709  Optineb S/N's   20900255 20900269 20900281 20900313   20900282 20900270 20900287 20900314", "more_code_info": ""}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-212-2014", "product_description": "Methylprednisolone 20mg PF 5ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "40 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Cherry Hill", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018140"], "brand_name": ["ATIVAN"], "generic_name": ["LORAZEPAM"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0641-6000", "0641-6003", "0641-6002", "0641-6001"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["LORAZEPAM"], "rxcui": ["206819", "206820", "238100", "238101", "1665188", "1665190", "1665326", "1665327"], "spl_id": ["209b0091-c890-4f69-a693-d0594c2606fe"], "spl_set_id": ["5fc0e987-61c9-40c4-b0d5-fcea07c8733e"], "package_ndc": ["0641-6003-01", "0641-6003-25", "0641-6002-01", "0641-6002-10", "0641-6001-01", "0641-6001-25", "0641-6000-01", "0641-6000-10"], "is_original_packager": [true], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["O26FZP769L"]}, "product_type": "Drugs", "event_id": "90583", "recalling_firm": "Hikma Pharmaceuticals USA Inc.", "address_1": "2 Esterbrook Ln", "address_2": "", "postal_code": "08003-4002", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1308-2022", "product_description": "Ativan Injection (lorazepam injection, USP), 2mg/mL, 1 mL vial,  25 vials per carton, RX Only, Manufactured by West-Ward Eatontown, NJ 07724, Carton NDC# 0641-6001-25, Vial NDC# 0641-6001-01", "product_quantity": "301,400 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.", "recall_initiation_date": "20220711", "center_classification_date": "20220805", "termination_date": "20230914", "report_date": "20220817", "code_info": "Lot # 060064Z, Exp. 06/2023", "more_code_info": ""}, {"status": "Ongoing", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94354", "recalling_firm": "ARG Laboratories, Inc.", "address_1": "2639 Manana Dr", "address_2": "", "postal_code": "75220-1301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0525-2024", "product_description": "Pain Wizard, Natural Relief for Muscular & Arthritic Pain, (Camphor 3%, Menthol 3%),  Enriched with Capsaicin, Camphor, Menthol & MSM, Tube, NET WT 4oz (113.39g), painwizard.com Made in the USA, PO Box 1099, Johnstown, CO 80534, UPC 8 63865 00019 2", "product_quantity": "2,864", "reason_for_recall": "Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.", "recall_initiation_date": "20240417", "center_classification_date": "20240530", "report_date": "20240605", "code_info": "Lot , 06023C1, Exp 01/31/2025,", "more_code_info": ""}, {"status": "Terminated", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077090"], "brand_name": ["LEFLUNOMIDE"], "generic_name": ["LEFLUNOMIDE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-2502", "60505-2503"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEFLUNOMIDE"], "rxcui": ["205284", "205285"], "spl_id": ["ebee26d4-bf2a-e0eb-b0f4-e1212d0bed03"], "spl_set_id": ["753453c5-8a7a-878e-3ce7-1d1edce718a9"], "package_ndc": ["60505-2502-1", "60505-2502-2", "60505-2502-3", "60505-2503-1", "60505-2503-2", "60505-2503-3"], "is_original_packager": [true], "nui": ["N0000175713"], "pharm_class_epc": ["Antirheumatic Agent [EPC]"], "unii": ["G162GK9U4W"]}, "product_type": "Drugs", "event_id": "38329", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy", "address_2": "Ste 400", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "Nationwide.", "recall_number": "D-1661-2012", "product_description": "Leflunomide tablets, 10 mg, a) 30-count bottle (NDC 60505-2502-1), b) 1000-count bottle (NDC 60505-2502-3), Rx only, Manufactured for Apotex Corp., Weston, Florida 33326 by Apotex Inc., Toronto, Ontario Canada M9L 1T9", "product_quantity": "3063", "reason_for_recall": "Subpotent (Single Ingredient Drug): Distribution of product that did not meet specifications.", "recall_initiation_date": "20070614", "center_classification_date": "20120827", "termination_date": "20120828", "report_date": "20120905", "code_info": "Lot #: a) GY4197, Exp 11/07; b) GZ1273, Exp 11/07."}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077653"], "brand_name": ["VENLAFAXINE"], "generic_name": ["VENLAFAXINE"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-018", "68382-019", "68382-020", "68382-021", "68382-101"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VENLAFAXINE HYDROCHLORIDE"], "rxcui": ["313580", "313582", "313584", "313586", "314277"], "spl_id": ["ea404f6c-7e07-4779-a52c-8cffb92718ef"], "spl_set_id": ["72efad5f-0909-46a5-aa13-ac24fe015fe6"], "package_ndc": ["68382-018-06", "68382-018-14", "68382-018-16", "68382-018-01", "68382-018-05", "68382-018-10", "68382-019-06", "68382-019-14", "68382-019-16", "68382-019-01", "68382-019-05", "68382-019-10", "68382-020-06", "68382-020-14", "68382-020-16", "68382-020-01", "68382-020-05", "68382-020-10", "68382-021-06", "68382-021-14", "68382-021-16", "68382-021-01", "68382-021-05", "68382-021-10", "68382-101-06", "68382-101-14", "68382-101-16", "68382-101-01", "68382-101-05", "68382-101-10"], "is_original_packager": [true], "upc": ["0368382019011", "0368382018014", "0368382021014", "0368382101013"], "unii": ["7D7RX5A8MO"]}, "product_type": "Drugs", "event_id": "96553", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "US Nationwide.", "recall_number": "D-0310-2025", "product_description": "Venlafaxine Tablets, USP, 75 mg, 100 Tablets, Rx only, Mfg. by: Zydus Lifesciences Ltd, Ahmedabad, India, Dist. by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-021-01.", "product_quantity": "13,128 100-Count Bottles", "reason_for_recall": "Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.", "recall_initiation_date": "20250321", "center_classification_date": "20250404", "report_date": "20250416", "code_info": "Lot #: M314265, Exp.: 31 October 2025."}, {"country": "United States", "city": "Glasgow", "address_1": "1220 N Race St", "reason_for_recall": "Lack of Assurance of Sterility: A recent FDA inspection of Vann Healthcare Services facility revealed deficiencies that raise concerns about the pharmacy's ability to consistently assure sterility of their products.", "address_2": "", "product_quantity": "1 vial", "code_info": "Lot #: 071714A", "center_classification_date": "20141219", "distribution_pattern": "KY", "state": "KY", "product_description": "Hydroxyprogesterone Caproate, 250 mg per mL, 5 mL vial, Rx, Vann Healthcare Pharmacy, 1220 N Race Street, Glasgow, KY 42141", "report_date": "20141231", "classification": "Class II", "openfda": {}, "recalling_firm": "Vann Healthcare Services Inc", "recall_number": "D-0309-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "69633", "termination_date": "20150701", "more_code_info": "", "recall_initiation_date": "20141014", "postal_code": "42141-3462", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Venice", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87828", "recalling_firm": "Scentsational Soaps & Candles Inc", "address_1": "730 Commerce Dr", "address_2": "N/A", "postal_code": "34292-1726", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0668-2021", "product_description": "SS Eucalyptus Mint Scented Sanitizer, Alcohol Antiseptic 70%, Non-sterile Topical Solution, 3.38 FL. OZ. (100 mL), a) Black and White Collection; b) Photo Real Collection", "product_quantity": "a) 4,248 bottles; b) 3,960 bottles", "reason_for_recall": "Chemical contamination: product found to be contaminated with methanol (wood alcohol), benzene and acetaldehyde.", "recall_initiation_date": "20210427", "center_classification_date": "20210719", "termination_date": "20221202", "report_date": "20210728", "code_info": "Lot #: 20248", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "200 gm", "code_info": "All lots distributed between November 2014 and May 2015    01282015@15 and 03182015@54", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Neomycin + Polymyxin B+ Bacitracin Ophthalmic Ointment, grams, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1618-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1816-2019", "product_description": "VELCADE 2.1 mg / 0.84 ml SQ SYRINGE; VELCADE 2.5 MG/ 1 ML SUB-Q SYRINGE; VELCADE 2.2 MG/ 0.88 ML SUB-Q SYRINGE; VELCADE 2.6 MG (1.04 ML) Sub Q SYRINGE; VELCADE 4 mg / 1.6 ml SQ SYRINGE; VELCADE 2.75 mg / 1.1 ml SQ SYRINGE; VELCADE 2.6 mg / 1.04 ml SQ SYRINGE  VELCADE 1.7 mg / 0.68 ml SQ SYRINGE; VELCADE 3.5 mg / 1.4 ML SQ SYRINGE; VELCADE 2.2 mg / 0.88 ml SQ SYRINGE; VELCADE 2.33 MG/ 0.93 ML SUB-Q SYRINGE; VELCADE 2.4 MG/ 0.96 ML SUB-Q SYRINGE  VELCADE 2.63 MG/ 1.052 ML SUB-Q SYRINGE, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Colonia", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83427", "recalling_firm": "Colonia Care Pharmacy", "address_1": "515 Inman Ave Ste A", "address_2": "N/A", "postal_code": "07067-1114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Patient Specific Prescriptions in NJ", "recall_number": "D-0034-2020", "product_description": "C-VERAPAMIL 2.5MG/ML INJ SOLN, 10 mL vial, Rx only, Colonia Care Pharmacy, 515 Inman Ave., Suite A, Colonia, N.J. 07067", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility: product sterility cannot be guaranteed.", "recall_initiation_date": "20190724", "center_classification_date": "20191001", "termination_date": "20230405", "report_date": "20191009", "code_info": "Lot #: 072319A, BUD 09/06/19"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0392-2017", "product_description": "Sermorelin Acetate/GHRP (2) Kit 6 mg/4.5 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "176 kits (number of vials per kit vary by prescription)", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known kit lot code: 04062016@170, 05272016@67, 09132016@98.  Known vial lot code: 03302016@12, 050412016@84, 08222016@27."}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "1588 ml total", "code_info": "All lots distributed between November 2014 and May 2015;  03022015@86, 5/31/2015; 04012015@71, 6/30/2015; 02202015@43, 5/21/2015,; 2232015@74, 5/24/2015; 02272015@70, 5/28/2015; 03052015@8, 6/3/2015; 03102015@61, 6/8/2015; 03092015@97, 6/7/2015; 03202015@98, 6/18/2015; 03232015@62, 6/21/2015; 03272015@50, 6/25/2015; 03312015@47, 6/29/2015; 04022015@20, 7/1/2015; 04062015@1, 7/5/2015; 04062015@61, 7/5/2015; 04132015@49, 7/12/2015; 04132015@53, 7/12/2015; 04152015@26, 7/14/2015; 04162015@20, 7/15/2015; 04222015@41, 7/21/2015; 04162015@50, 7/15/2015; 05012015@52, 7/30/2015; 04242015@64, 7/1/2015; 04302015@3, 7/29/2015; 04302015@40, 7/29/2015; 04302015@43, 7/29/2015; 04292015@99, 7/28/2015; 05062015@19, 8/4/2015; 05122015@14, 7/11/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Methylcobalamin 1,000 mcg/ml Injectable, Multi-Dose Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1569-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "74723", "recalling_firm": "The Harvard Drug Group", "address_1": "31778 Enterprise Dr", "address_2": "N/A", "postal_code": "48150-1960", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0022-2017", "product_description": "Diocto Liquid (docusate sodium) 50 mg/5 mL Stool Softener Laxative, One Pint (473 mL) bottles, Dist by: Rugby Laboratories, Livonia, MI --- NDC 0536-0590-85", "product_quantity": "153,432 bottles", "reason_for_recall": "Microbial contamination of Non-Sterile Products; positive findings of Burkholderia cepacia", "recall_initiation_date": "20160715", "center_classification_date": "20161012", "termination_date": "20170327", "report_date": "20161019", "code_info": "20351407, 20351408, exp 09/16; 20351409, exp 11/16; 20351410, exp 12/16; 20351501, 20351502, exp 01/17; 20351503, exp 03/17; 20351504, exp 04/17; 20351505, exp 05/17; 20351506, 20351507, exp 06/17; 20351508, exp 07/17, 20351509, 20351510, exp 10/17; 20351511, 20351512, 20351513, exp 11/17; 20351601, exp 01/18; 20351602, exp 02/18; 20351603, exp 03/18; 20351604, 20351605, exp 04/18"}]